Skip to main content
OpenTrials

Clinical trial condition

Epstein-Barr Virus Infections

Explore clinical trials studying Epstein-Barr Virus Infections. Study availability and eligibility vary by location and protocol.

692 public trials 114 recruiting studies
Refine in advanced search Browse all conditions

Epstein-Barr Virus Infections trial results

Recruiting

NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)

NCT07502118

Conditions
Burkitt Lymphoma, Cytokine Release Syndrome, DNA Virus Infections, +29 more
Locations
  • Ankara Bilkent City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
  • Ankara Etlik City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
  • Hacettepe University Faculty of Medicine - Department of Internal Medicine, Division of Hematology Ankara, Turkey (Türkiye)
  • University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Ankara, Turkey (Türkiye)
View Trial Details
Recruiting

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

NCT06918431

Conditions
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt Lymphoma, DNA Virus Infections, +20 more
Locations
  • City of Hope at Phoenix Phoenix, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View Trial Details
Recruiting

Recommendations for the Treatment of Children With Burkitt's Lymphoma

NCT04425421

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +14 more
Locations
  • Hopital Yalgado Ouedraogo Ouagadougou, Burkina Faso
  • CHU de Treichville à ABIDJAN Abidjan, Côte d’Ivoire
  • Cliniques Universitaires de Kinshasa Kinshasa, Kinshasa City, Democratic Republic of the Congo
  • Cliniques Universitaires de Lubumbashi (CUL) Lubumbashi, Democratic Republic of the Congo
View Trial Details
Recruiting

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

NCT06173518

Conditions
Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +24 more
Locations
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Methodist Children's Hospital San Antonio, Texas, United States
  • Primary Children's Hospital Salt Lake City, Utah, United States
  • Hospital Vall d'Hebron Barcelona, Spain
View Trial Details

Related conditions